G D Abhilashini1, Haritha Sagili2, Rani Reddi3. 1. Junior Resident, Department of Obstetrics and Gynaecology, JIPMER , Pondicherry, India . 2. Assistant Professor, Department of Obstetrics and Gynaecology, JIPMER , Pondicherry, India . 3. Professor, Department of Obstetrics and Gynaecology, JIPMER , Pondicherry, India .
Abstract
PURPOSE: The aim of this study was to compare the efficacy and safety of intravenous iron sucrose and oral iron administration for the treatment of iron deficiency anaemia in pregnancy. MATERIALS AND METHODS:Hundred women with gestational age between 30 and 34 weeks with established iron deficiency anaemia with Haemoglobin-6-8g/dL were randomised to receive either oral ferrous sulphate 200 mg thrice daily or required dose of intravenous iron sucrose 200 mg in 200 ml NS on alternate days. Haemoglobin, haematocrit, mean corpuscular volume, reticulocyte count were measured at recruitment and on 2(nd) week, 4(th) week and at 37 weeks. Adverse drug reactions were also noted in both the groups. RESULTS were analyzed by student's t-test and Chi-square test. RESULTS:Haemoglobin values varied significantly with time between the two groups at second week, 4(th) week and at term (p<0.005). The mean difference in mean corpuscular volume from the recruitment value was not significant at 2(nd) week. When compared to iron sucrose group, oral iron group had significant gastro-intestinal adverse effects. CONCLUSION:Intravenous iron sucrose treated iron deficiency anaemia of pregnancy faster, and more effectively than oral iron therapy, with no serious adverse drug reactions.
RCT Entities:
PURPOSE: The aim of this study was to compare the efficacy and safety of intravenous iron sucrose and oral iron administration for the treatment of iron deficiency anaemia in pregnancy. MATERIALS AND METHODS: Hundred women with gestational age between 30 and 34 weeks with established iron deficiency anaemia with Haemoglobin-6-8g/dL were randomised to receive either oral ferrous sulphate 200 mg thrice daily or required dose of intravenous iron sucrose 200 mg in 200 ml NS on alternate days. Haemoglobin, haematocrit, mean corpuscular volume, reticulocyte count were measured at recruitment and on 2(nd) week, 4(th) week and at 37 weeks. Adverse drug reactions were also noted in both the groups. RESULTS were analyzed by student's t-test and Chi-square test. RESULTS: Haemoglobin values varied significantly with time between the two groups at second week, 4(th) week and at term (p<0.005). The mean difference in mean corpuscular volume from the recruitment value was not significant at 2(nd) week. When compared to iron sucrose group, oral iron group had significant gastro-intestinal adverse effects. CONCLUSION: Intravenous iron sucrose treated iron deficiency anaemia of pregnancy faster, and more effectively than oral iron therapy, with no serious adverse drug reactions.
Entities:
Keywords:
Iron deficiency anaemia; Iron sucrose; Oral iron therapy
Authors: A K al-Momen; A al-Meshari; L al-Nuaim; A Saddique; Z Abotalib; T Khashogji; M Abbas Journal: Eur J Obstet Gynecol Reprod Biol Date: 1996-11 Impact factor: 2.435
Authors: A Khalafallah; A Dennis; J Bates; G Bates; I K Robertson; L Smith; M J Ball; D Seaton; T Brain; J E J Rasko Journal: J Intern Med Date: 2010-05-19 Impact factor: 8.989
Authors: Sarah Samsudin; Mairin Dulasi; Salina Sany; Kathirgamanathan Balanathan; Soon Eu Chong; Anizah Ali Journal: Int J Womens Health Date: 2020-12-30
Authors: Akshay A Shah; Killian Donovan; Claire Seeley; Edward A Dickson; Antony J R Palmer; Carolyn Doree; Susan Brunskill; Jack Reid; Austin G Acheson; Anita Sugavanam; Edward Litton; Simon J Stanworth Journal: JAMA Netw Open Date: 2021-11-01